본문 바로가기
KERD
논문KCI 등재

Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis

Jung Byung-Kwon|Ryu Kwon-Yul
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 2138-2146|DOI 10.1038/s12276-023-01098-7

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Glial cell activation precedes neuronal cell death during brain aging and the progression of neurodegenerative diseases. Under neuroinflammatory stress conditions, lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin or 24p3, is produced and secreted by activated microglia and reactive astrocytes. Lcn2 expression levels are known to be increased in various cells, including reactive astrocytes, through the activation of the NF-κB signaling pathway. In the central nervous system, as LCN2 exerts neurotoxicity when secreted from reactive astrocytes, many researchers have attempted to identify various strategies to inhibit LCN2 production, secretion, and function to minimize neuroinflammation and neuronal cell death. These strategies include regulation at the transcriptional, posttranscriptional, and posttranslational levels, as well as blocking its functions using neutralizing antibodies or antagonists of its receptor. The suppression of NF-κB signaling is a strategy to inhibit LCN2 production, but it may also affect other cellular activities, raising questions about its effectiveness and feasibility. Recently, LCN2 was found to be a target of the autophagy‒lysosome pathway. Therefore, autophagy activation may be a promising therapeutic strategy to reduce the levels of secreted LCN2 and overcome neurodegenerative diseases. In this review, we focused on research progress on astrocyte-derived LCN2 in the central nervous system.

Abstract

Glial cell activation precedes neuronal cell death during brain aging and the progression of neurodegenerative diseases. Under neuroinflammatory stress conditions, lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin or 24p3, is produced and secreted by activated microglia and reactive astrocytes. Lcn2 expression levels are known to be increased in various cells, including reactive astrocytes, through the activation of the NF-κB signaling pathway. In the central nervous system, as LCN2 exerts neurotoxicity when secreted from reactive astrocytes, many researchers have attempted to identify various strategies to inhibit LCN2 production, secretion, and function to minimize neuroinflammation and neuronal cell death. These strategies include regulation at the transcriptional, posttranscriptional, and posttranslational levels, as well as blocking its functions using neutralizing antibodies or antagonists of its receptor. The suppression of NF-κB signaling is a strategy to inhibit LCN2 production, but it may also affect other cellular activities, raising questions about its effectiveness and feasibility. Recently, LCN2 was found to be a target of the autophagy‒lysosome pathway. Therefore, autophagy activation may be a promising therapeutic strategy to reduce the levels of secreted LCN2 and overcome neurodegenerative diseases. In this review, we focused on research progress on astrocyte-derived LCN2 in the central nervous system.

참고문헌 (118)

  1. Nimmerjahn, A., "Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo", Science, 308, pp.1314~1318 (2005)
  2. Freeman, M. R., "Specification and morphogenesis of astrocytes", Science, 330, pp.774~778 (2010)
  3. Aguzzi, A., "Microglia : scapegoat, saboteur, or something else?", Science, 339, pp.156~161 (2013)
  4. Li, Q., "Microglia and macrophages in brain homeostasis and disease", Nat. Rev. Immunol, 18, pp.225~242 (2018)
  5. Li, K., "Reactive astrocytes in neurodegenerative diseases", Aging Dis, 10, pp.664~675 (2019)
  6. Linnerbauer, M., "Astrocyte crosstalk in CNS inflammation", Neuron, 108, pp.608~622 (2020)
  7. Lee, H. G., "Function and therapeutic value of astrocytes in neurological diseases", Nat. Rev. Drug Discov, 21, pp.339~358 (2022)
  8. Lian, H., "NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer’s disease", Neuron, 85, pp.101~115 (2015)
  9. Zheng, H., "beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity", Cell, 81, pp.525~531 (1995)
  10. Ryu, K. Y., "Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the Ubb polyubiquitin gene", Proc. Natl. Acad. Sci. USA, 105, pp.4016~4021 (2008)
  11. Ryu, K. Y., "Loss of polyubiquitin gene Ubb leads to metabolic and sleep abnormalities in mice", Neuropathol. Appl. Neurobiol, 36, pp.285~299 (2010)
  12. Okada, S., "Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury", Nat. Med, 12, pp.829~834 (2006)
  13. Liddelow, S. A., "Neurotoxic reactive astrocytes are induced by activated microglia", Nature, 541, pp.481~487 (2017)
  14. Smith, H. L., "Astrocyte unfolded protein response induces a specific reactivity state that causes non-cell-autonomous neuronal degeneration", Neuron, 105, pp.855~866 (2020)
  15. Fujino, R. S., "Spermatogonial cell-mediated activation of an IkappaBzetaindependent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene", Mol. Endocrinol, 20, pp.904~915 (2006)
  16. Zhao, P., "STAT1, NF-kappaB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes", Mol. Metab, 2, pp.161~170 (2013)
  17. Liu, T., "NF-kappaB signaling in inflammation", Signal Transduct. Target Ther, 2, pp.17023~ (2017)
  18. Kjeldsen, L., "Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase", J. Biol. Chem, 268, pp.10425~10432 (1993)
  19. Kjeldsen, L., "Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils", Blood, 83, pp.799~807 (1994)
  20. Cowland, J. B., "Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans", Genomics, 45, pp.17~23 (1997)
  21. Ip, J. P., "Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration", J. Neuroinflammation, 8, pp.124~ (2011)
  22. Jung, B. K., "Reduced secretion of LCN2(lipocalin 2)from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage", Autophagy, 19, pp.2296~2317 (2023)
  23. Suk, K., "Lipocalin-2 as a therapeutic target for brain injury : an astrocentric perspective", Prog. Neurobiol, 144, pp.158~172 (2016)
  24. Devireddy, L. R., "A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake", Cell, 123, pp.1293~1305 (2005)
  25. Choi, J., "Increased plasma levels of lipocalin 2 in mild cognitive impairment", J. Neurol. Sci, 305, pp.28~33 (2011)
  26. Somjen, G. G., "Nervenkitt: notes on the history of the concept of neuroglia", Glia, 1, pp.2~9 (1988)
  27. Azevedo, F. A., "Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain", J. Comp. Neurol, 513, pp.532~541 (2009)
  28. Greenhalgh, A. D., "Immune cell regulation of glia during CNS injury and disease", Nat. Rev. Neurosci, 21, pp.139~152 (2020)
  29. Allen, N. J., "Glia as architects of central nervous system formation and function", Science, 362, pp.181~185 (2018)
  30. Ffrench-Constant, C., "Proliferating bipotential glial progenitor cells in adult rat optic nerve", Nature, 319, pp.499~502 (1986)
  31. Bergles, D. E., "Oligodendrocyte development and plasticity", Cold Spring Harb. Perspect. Biol, 8, pp.a020453~ (2015)
  32. Ginhoux, F., "Origin and differentiation of microglia", Front. Cell Neurosci, 7, pp.45~ (2013)
  33. Ge, W. P., "Local generation of glia is a major astrocyte source in postnatal cortex", Nature, 484, pp.376~380 (2012)
  34. Andriezen, W. L., "The neuroglia elements in the human brain", Br. Med. J, 2, pp.227~230 (1893)
  35. Barres, B. A., "The mystery and magic of glia: a perspective on their roles in health and disease", Neuron, 60, pp.430~440 (2008)
  36. Herrmann, J. E., "STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury", J. Neurosci, 28, pp.7231~7243 (2008)
  37. Sofroniew, M. V., "Astrocytes : biology and pathology", Acta Neuropathol, 119, pp.7~35 (2010)
  38. Abbott, N. J., "Astrocyte-endothelial interactions at the blood-brain barrier", Nat. Rev. Neurosci, 7, pp.41~53 (2006)
  39. Gordon, G. R. J, "Astrocyte control of the cerebrovasculature", Glia, 55, pp.1214~1221 (2007)
  40. Iadecola, C., "Glial regulation of the cerebral microvasculature", Nat. Neurosci, 10, pp.1369~1376 (2007)
  41. Schummers, J., "Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex", Science, 320, pp.1638~1643 (2008)
  42. Simard, M., "The neurobiology of glia in the context of water and ion homeostasis", Neuroscience, 129, pp.877~896 (2004)
  43. Seifert, G., "Astrocyte dysfunction in neurological disorders : a molecular perspective", Nat. Rev. Neurosci, 7, pp.194~206 (2006)
  44. Christopherson, K. S., "Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis", Cell, 120, pp.421~433 (2005)
  45. Stevens, B., "The classical complement cascade mediates CNS synapse elimination", Cell, 131, pp.1164~1178 (2007)
  46. Sofroniew, M. V., "Molecular dissection of reactive astrogliosis and glial scar formation", Trends Neurosci, 32, pp.638~647 (2009)
  47. Xiong, Y., "Animal models of traumatic brain injury", Nat. Rev. Neurosci, 14, pp.128~142 (2013)
  48. Shively, S. B., "Characterisation of interface astroglial scarring in the human brain after blast exposure : a post-mortem case series", Lancet Neurol, 15, pp.944~953 (2016)
  49. Trendelenburg, G., "Neuroprotective role of astrocytes in cerebral ischemia : focus on ischemic preconditioning", Glia, 50, pp.307~320 (2005)
  50. Voskuhl, R. R., "Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS", J. Neurosci, 29, pp.11511~11522 (2009)
  51. Medeiros, R., "Astrocytes : conductors of the Alzheimer disease neuroinflammatory symphony", Exp. Neurol, 239, pp.133~138 (2013)
  52. Heneka, M. T., "Neuroinflammation in Alzheimer’s disease", Lancet Neurol, 14, pp.388~405 (2015)
  53. Bush, T. G., "Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice", Neuron, 23, pp.297~308 (1999)
  54. Pekny, M., "The dual role of astrocyte activation and reactive gliosis", Neurosci. Lett, 565, pp.30~38 (2014)
  55. Pekny, M., "Astrocyte intermediate filaments in CNS pathologies and regeneration", J. Pathol, 204, pp.428~437 (2004)
  56. Eng, L. F., "Glial fibrillary acidic protein : GFAP-thirty-one years(1969-2000)", Neurochem. Res, 25, pp.1439~1451 (2000)
  57. Salas, I. H., "Glia : victims or villains of the aging brain?", Neurobiol. Dis, 143, pp.105008~ (2020)
  58. Safaiyan, S., "Age-related myelin degradation burdens the clearance function of microglia during aging", Nat. Neurosci, 19, pp.995~998 (2016)
  59. Jha, M. K., "Functional dissection of astrocyte-secreted proteins : Implications in brain health and diseases", Prog. Neurobiol, 162, pp.37~69 (2018)
  60. Stephan, A. H., "The complement system : an unexpected role in synaptic pruning during development and disease", Annu. Rev. Neurosci, 35, pp.369~389 (2012)
  61. Mayeux, R., "A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender", Arch. Neurol, 49, pp.492~497 (1992)
  62. Gao, S., "The relationships between age, sex, and the incidence of dementia and Alzheimer disease : a meta-analysis", Arch. Gen. Psychiatry, 55, pp.809~815 (1998)
  63. Wyss-Coray, T., "Ageing, neurodegeneration and brain rejuvenation", Nature, 539, pp.180~186 (2016)
  64. Hou, Y., "Ageing as a risk factor for neurodegenerative disease", Nat. Rev. Neurol, 15, pp.565~581 (2019)
  65. Lopez-Otin, C., "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
  66. Bi, F., "Reactive astrocytes secrete lcn2 to promote neuron death", Proc. Natl. Acad. Sci. USA, 110, pp.4069~4074 (2013)
  67. Sofroniew, M. V., "Astrocyte reactivity : subtypes, states, and functions in CNS innate immunity", Trends Immunol, 41, pp.758~770 (2020)
  68. Escartin, C., "Reactive astrocyte nomenclature, definitions, and future directions", Nat. Neurosci, 24, pp.312~325 (2021)
  69. Zamanian, J. L., "Genomic analysis of reactive astrogliosis", J. Neurosci, 32, pp.6391~6410 (2012)
  70. Xing, C., "Neuronal production of lipocalin-2 as a help-me signal for glial activation", Stroke, 45, pp.2085~2092 (2014)
  71. Liddelow, S. A., "Reactive astrocytes: production, function, and therapeutic potential", Immunity, 46, pp.957~967 (2017)
  72. Paolicelli, R. C., "Microglia states and nomenclature : a field at its crossroads", Neuron, 110, pp.3458~3483 (2022)
  73. Anderson, M. A., "Astrocyte scar formation aids central nervous system axon regeneration", Nature, 532, pp.195~200 (2016)
  74. Ransohoff, R. M., "A polarizing question : do M1 and M2 microglia exist?", Nat. Neurosci, 19, pp.987~991 (2016)
  75. Colonna, M., "Microglia function in the central nervous system during health and neurodegeneration", Annu. Rev. Immunol, 35, pp.441~468 (2017)
  76. Tarassishin, L., "Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*", Glia, 59, pp.1911~1922 (2011)
  77. Yang, J., "An iron delivery pathway mediated by a lipocalin", Mol. Cell, 10, pp.1045~1056 (2002)
  78. Flo, T. H., "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
  79. Abella, V., "The potential of lipocalin-2", NGAL as biomarker for inflammatory and metabolic diseases, 2015, pp.20, 565~571
  80. Xiao, X., "Lipocalin 2 : an emerging player in iron homeostasis and inflammation", Annu. Rev. Nutr, 37, pp.103~130 (2017)
  81. Mishra, J., "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury", J. Am. Soc. Nephrol, 14, pp.2534~2543 (2003)
  82. Neilands, J. B, "Siderophores: structure and function of microbial iron transport compounds", J. Biol. Chem, 270, pp.26723~26726 (1995)
  83. Berger, T., "Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury", Proc. Natl. Acad. Sci. USA, 103, pp.1834~1839 (2006)
  84. Liu, Q., "Uterocalin : a mouse acute phase protein expressed in the uterus around birth", Mol. Reprod. Dev, 46, pp.507~514 (1997)
  85. Bennett, M., "Urine NGAL predicts severity of acute kidney injury after cardiac surgery : a prospective study", Clin. J. Am. Soc. Nephrol, 3, pp.665~673 (2008)
  86. Shao, S., "Increased lipocalin-2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion", J. Investig. Dermatol, 136, pp.1418~1428 (2016)
  87. Borkham-Kamphorst, E., "Protective effects of lipocalin-2(LCN2)in acute liver injury suggest a novel function in liver homeostasis", Biochim. Biophys. Acta, 1832, pp.660~673 (2013)
  88. Dong, M., "Role of iron in brain lipocalin 2 upregulation after intracerebral hemorrhage in rats", Brain Res, 1505, pp.86~92 (2013)
  89. Moschen, A. R., "Lipocalin-2 : a master mediator of intestinal and metabolic inflammation", Trends Endocrinol. Metab, 28, pp.388~397 (2017)
  90. Lee, S., "Lipocalin-2 is an autocrine mediator of reactive astrocytosis", J. Neurosci, 29, pp.234~249 (2009)
  91. Ferreira, A. C., "From the periphery to the brain: Lipocalin-2, a friend or foe?", Prog. Neurobiol, 131, pp.120~136 (2015)
  92. Kang, S. S., "Lipocalin-2 protects the brain during inflammatory conditions", Mol. Psychiatry, 23, pp.344~350 (2018)
  93. Jha, M. K., "Diverse functional roles of lipocalin-2 in the central nervous system", Neurosci. Biobehav. Rev, 49, pp.135~156 (2015)
  94. 진명원, "Lipocalin-2 Acts as a Neuroinflammatogen in Lipopolysaccharide-injected Mice", Experimental Neurobiology, 23(2), pp.155~162 (2014), 한국뇌신경과학회
  95. Hong, J., "Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation", Sci. Rep, 10, pp.13337~ (2020)
  96. Jin, M., "Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice", J. Cereb. Blood Flow. Metab, 34, pp.1306~1314 (2014)
  97. Nam, Y., "Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis : the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues", J. Biol. Chem, 289, pp.16773~16789 (2014)
  98. Lee, S., "A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia", J. Immunol, 179, pp.3231~3241 (2007)
  99. Cserep, C., "Shaping neuronal fate : functional heterogeneity of direct microglia-neuron interactions", Neuron, 109, pp.222~240 (2021)
  100. Jack, C. S., "TLR signaling tailors innate immune responses in human microglia and astrocytes", J. Immunol, 175, pp.4320~4330 (2005)
  101. Liu, L. R., "Interaction of microglia and astrocytes in the neurovascular unit", Front Immunol, 11, pp.1024~ (2020)
  102. Larsen, M. T., "miRNA-130a regulates C", EBP-epsilon expression during granulopoiesis, 2014, pp.123, 1079~1089
  103. Xiong, H., "Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression", Exp. Biol. Med, 241, pp.25~30 (2016)
  104. Chan, Y. K., "Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells", Mol. Cell Endocrinol, 430, pp.68~76 (2016)
  105. Langelueddecke, C., "Lipocalin-2(24p3", neutrophil gelatinase-associated lipocalin(NGAL))receptor is expressed in distal nephron and mediates protein endocytosis, 2012, pp.287, 159~169
  106. Xu, G., "Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation", J. Biol. Chem, 287, pp.4808~4817 (2012)
  107. Song, E., "Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice", J. Am. Heart Assoc, 3, pp.e000837~ (2014)
  108. Goetz, D. H., "Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin", Biochemistry, 39, pp.1935~1941 (2000)
  109. Chun, H., "Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H(2)O(2)(-)production", Nat. Neurosci, 23, pp.1555~1566 (2020)
  110. Rothhammer, V., "Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation", Proc. Natl. Acad. Sci. USA, 114, pp.2012~2017 (2017)
  111. Hara, T., "Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice", Nature, 441, pp.885~889 (2006)
  112. Nedelsky, N. B., "Autophagy and the ubiquitinproteasome system : collaborators in neuroprotection", Biochim. Biophys. Acta, 1782, pp.691~699 (2008)
  113. Zheng, Q., "Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases", Front. Aging Neurosci, 8, pp.303~ (2016)
  114. Zhang, Y., "The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer’s disease", Rev. Neurosci, 28, pp.861~868 (2017)
  115. Park, C. W., "Reduced free ubiquitin levels and proteasome activity in cultured neurons and brain tissues treated with amyloid beta aggregates", Mol. Brain, 13, pp.89~ (2020)
  116. Bae, J. S., "Cytoprotective role of ubiquitin against toxicity induced by polyglutamine-expanded aggregates", Biochem. Biophys. Res. Commun, 500, pp.344~350 (2018)
  117. Park, C. W., "Simultaneous disruption of both polyubiquitin genes affects proteasome function and decreases cellular proliferation", Cell Biochem. Biophys, 78, pp.321~329 (2020)
  118. Jung, B. K., "Temporal downregulation of the polyubiquitin gene Ubb affects neuronal differentiation, but not maturation, in cells cultured in vitro", Sci. Rep, 8, pp.2629~ (2018)

관련 논문AI추천

Modulation of Glial and Neuronal Migration by Lipocalin-2 in Zebrafish김호, 박해철, 석경호, 이명식, 이신려, 이원하대한면역학회 · Immune Network2011 · 제11권 제6호Acute Phase Protein Lipocalin-2 Is Associated with Formalin-induced Nociception and Pathological Pain석경호, 이원하, Mithilesh Kumar Jha, Myungwon Jin, Sangmin Jeon대한면역학회 · Immune Network2013 · 제13권 제6호Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease양승훈대한배뇨장애요실금학회 · International Neurourology Journal2019 · 제23권 제1호Pathological phenotypes of astrocytes in Alzheimer’s disease유익동, 임재준, Kim Junhyung, Moon Jong-Seok생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Piper Longum’s Neuroprotective Role Against Amyloid-β and Okadaic Acid-Induced Toxicity in U87MG Cells Through the Lipocalin-2 PathwayCho Seung-Hun, Kim Yunna, Shin Seung-Min, Sung Seok-Hwan대한약침학회 · Journal of Pharmacopuncture2025 · 제28권 제2호HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain김승우, 이자경, Davaanyam Dashdulam, Lee Hahnbi, Oh Sang-A, Seol Song-I생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기